Dental products distributor Henry Schein beat third-quarter profit estimates on Tuesday, as a series of cost-saving measures helped counter tepid demand and slow recovery from a cyberattack it ...

For oral health professionals looking to purchase pink dental products, click here. For medical professionals looking to purchase pink products, click here. About Henry Schein, Inc. Henry Schein ...

The dental supplies firm raised the lower end of its 2024 adjusted earnings projection, and now anticipates a range between $4.74 and $4.82 a share, compared with the prior $4.70-to-$4.82 a share ...

On Tuesday, Henry Schein Inc. (NASDAQ:HSIC) reported a third-quarter adjusted EPS of $1.22, down 7.6% year-over-year, beating ...

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $79.5, a high estimate of $82.00, ...

Analyst Erin Wright of Morgan Stanley maintained a Sell rating on Henry Schein (HSIC – Research Report), retaining the price target of ...

These solutions also support dental laboratories ... with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers.

Henry Schein (HSIC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael ...

Q3 2024 Earnings Call Transcript November 5, 2024 Henry Schein, Inc. beats earnings expectations. Reported EPS is $1.22, ...

Our dental equipment business is showing ongoing stability in North America and increased investment by customers in Europe, Australia and New Zealand. Implant and endodontic products had good ...

Good morning, ladies and gentlemen, and welcome to Henry Schein's Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a ...